138 related articles for article (PubMed ID: 35861939)
41. The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest.
Cheng YW; Liao LD; Yang Q; Chen Y; Nie PJ; Zhang XJ; Xie JJ; Shan BE; Zhao LM; Xu LY; Li EM
Cell Biochem Funct; 2018 Dec; 36(8):398-407. PubMed ID: 30484863
[TBL] [Abstract][Full Text] [Related]
42. Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2-dependent pathway.
Liu D; Liu Y; Qi B; Gu C; Huo S; Zhao B
Cancer Med; 2021 Aug; 10(15):5235-5245. PubMed ID: 34160902
[TBL] [Abstract][Full Text] [Related]
43. WNT5A promotes the metastasis of esophageal squamous cell carcinoma by activating the HDAC7/SNAIL signaling pathway.
Feng Y; Ma Z; Pan M; Xu L; Feng J; Zhang Y; Shao C; Guo K; Duan H; Zhang Y; Zhang Y; Zhang J; Lu D; Ren X; Han J; Li X; Yan X
Cell Death Dis; 2022 May; 13(5):480. PubMed ID: 35595735
[TBL] [Abstract][Full Text] [Related]
44. Lysine-Specific Histone Demethylase 1 Promotes Oncogenesis of the Esophageal Squamous Cell Carcinoma by Upregulating DUSP4.
Han J; Ye S; Chen J; Wang K; Jin J; Zeng Z; Xue S
Biochemistry (Mosc); 2021 Dec; 86(12):1624-1634. PubMed ID: 34937541
[TBL] [Abstract][Full Text] [Related]
45. Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma.
Qie S; Yoshida A; Parnham S; Oleinik N; Beeson GC; Beeson CC; Ogretmen B; Bass AJ; Wong KK; Rustgi AK; Diehl JA
Nat Commun; 2019 Mar; 10(1):1296. PubMed ID: 30899002
[TBL] [Abstract][Full Text] [Related]
46. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.
Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma.
Zhu J; Wu G; Li Q; Gong H; Song J; Cao L; Wu S; Song L; Jiang L
Sci Rep; 2016 Feb; 6():21549. PubMed ID: 26899563
[TBL] [Abstract][Full Text] [Related]
48. Knockdown of zinc transporter ZIP5 (SLC39A5) expression significantly inhibits human esophageal cancer progression.
Jin J; Li Z; Liu J; Wu Y; Gao X; He Y
Oncol Rep; 2015 Sep; 34(3):1431-9. PubMed ID: 26133979
[TBL] [Abstract][Full Text] [Related]
49. MSP58 knockdown inhibits the proliferation of esophageal squamous cell carcinoma in vitro and in vivo.
Xu CS; Zheng JY; Zhang HL; Zhao HD; Zhang J; Wu GQ; Wu L; Wang Q; Wang WZ; Zhang J
Asian Pac J Cancer Prev; 2012; 13(7):3233-8. PubMed ID: 22994740
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
51. The effects of miR-429 on cell migration and invasion by targeting Slug in esophageal squamous cell carcinoma.
Zong M; Liu Y; Zhang K; J Y; Chen L
Pathol Res Pract; 2019 Sep; 215(9):152526. PubMed ID: 31324391
[TBL] [Abstract][Full Text] [Related]
52. IL-11 activated by lnc-ATB promotes cell proliferation and invasion in esophageal squamous cell cancer.
Yang SM; Li SY; Hao-Bin Y; Lin-Yan X; Sheng X
Biomed Pharmacother; 2019 Jun; 114():108835. PubMed ID: 30954889
[TBL] [Abstract][Full Text] [Related]
53. FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13.
Liu S; Huang M; Chen Z; Chen J; Chao Q; Yin X; Quan M
Exp Cell Res; 2020 Apr; 389(1):111894. PubMed ID: 32035950
[TBL] [Abstract][Full Text] [Related]
54. Upregulated long non‑coding RNA LincIN promotes tumor progression via the regulation of nuclear factor 90/microRNA‑7/HOXB13 in esophageal squamous cell carcinoma.
Tan Z; Zhou P; Zhu Z; Wang Y; Guo Z; Shen M; Xiao Y; Shen W; Wu D
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33693959
[TBL] [Abstract][Full Text] [Related]
55. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.
Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H
Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401
[TBL] [Abstract][Full Text] [Related]
56. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
[TBL] [Abstract][Full Text] [Related]
57. miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10.
Ding N; Sun X; Wang T; Huang L; Wen J; Zhou Y
Int J Mol Med; 2018 Jul; 42(1):381-391. PubMed ID: 29693138
[TBL] [Abstract][Full Text] [Related]
58. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
[TBL] [Abstract][Full Text] [Related]
59. PLCD1 Suppressed Cellular Proliferation, Invasion, and Migration via Inhibition of Wnt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.
He X; Meng F; Yu ZJ; Zhu XJ; Qin LY; Wu XR; Liu ZL; Li Y; Zheng YF
Dig Dis Sci; 2021 Feb; 66(2):442-451. PubMed ID: 32236884
[TBL] [Abstract][Full Text] [Related]
60. Minichromosome maintenance 6 complex component identified by bioinformatics analysis and experimental validation in esophageal squamous cell carcinoma.
Li X; Ren Z; Xiong C; Geng J; Li Y; Liu C; Ren C; Liu H
Oncol Rep; 2020 Sep; 44(3):987-1002. PubMed ID: 32583000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
